Chubb Q3 Core Operating Earnings Rise
MT newswire2026/10/20 20:25Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
S-Energy Clarifies Solar Contract Value at KRW 11.04 Billion, Reflecting Its Share
Why Snap Needed an Iron Man Star Before Its $2,195 Glasses Go on Sale
Profit surges; amid concerns over U.S. surgical volume, JPMorgan maintains "Overweight" on Intuitive Surgical (ISRG.US) and raises target price to $475
Intuitive Surgical (ISRG.US), the global leader in surgical robots, released its Q3 2026 earnings report on October 20 (U.S. Eastern Time). On the same day, JPMorgan published a research report, maintaining an "Overweight" rating on the stock.
Allergy and autoimmune biotechnology company Lycia Therapeutics (LYCA.US) sets IPO price at $16-18 per share, plans to raise $250 million
Lycia Therapeutics announced the terms of its initial public offering (IPO) on Tuesday.
Crypto prices
More
